Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study of LY3209590 in Participants With Type 1 Diabetes

ClinicalTrials.gov ID: NCT04450407

Public ClinicalTrials.gov record NCT04450407. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 9:12 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Parallel, Open-Label Comparator-Controlled Trial to Evaluate the Safety and Efficacy of LY3209590 in Study Participants With Type 1 Diabetes Mellitus Previously Treated With Multiple Daily Injection Therapy

Study identification

NCT ID
NCT04450407
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
266 participants

Conditions and interventions

Interventions

  • Insulin Degludec Drug
  • LY3209590 Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 5, 2020
Primary completion
Sep 30, 2021
Completion
Sep 30, 2021
Last update posted
Oct 26, 2022

2020 – 2021

United States locations

U.S. sites
33
U.S. states
16
U.S. cities
32
Facility City State ZIP Site status
John Muir Physician Network Clinical Research Center Concord California 94520
Valley Endocrine, Fresno Fresno California 93720
Coastal Metabolic Research Centre Ventura California 93003
Barbara Davis Center for Childhood Diabetes Aurora Colorado 80045
Denver Endocrinology, Diabetes & Thyroid Center Englewood Colorado 80113
East Coast Institute for Research at The Jones Center Jacksonville Florida 32204
Sun Coast Clinical Research, Inc New Port Richey Florida 34652
Bayside Clinical Research, LLC New Port Richey Florida 34655
Metabolic Research Institute, Inc. West Palm Beach Florida 33401
Atlanta Diabetes Associates Atlanta Georgia 30318
East Coast Institute for Research at The Jones Center Macon Georgia 31210
Endocrine Research Solutions, Inc. Roswell Georgia 30076
Rocky Mountain Clinical Research Idaho Falls Idaho 83404
Iowa Diabetes and Endocrinology Research Center West Des Moines Iowa 50265
Diabetes and Metabolism Associates, APMC Metairie Louisiana 70006
Endocrine and Metabolic Consultants Rockville Maryland 20852
Palm Research Center Tenaya Las Vegas Nevada 89128
Southern Nh Diabetes and Endocrinology Nashua New Hampshire 03060
Suny Health Science Center at Syracuse Syracuse New York 13210
Lucas Research, Inc. Morehead City North Carolina 28557
PMG Research of Piedmont Healthcare Statesville North Carolina 28625
PMG Research of Wilmington Wilmington North Carolina 28401
Intend Research, LLC Norman Oklahoma 73069
Holston Medical Group Bristol Tennessee 37620
Univ Diab & Endo Consult Chattanooga Tennessee 37411
Texas Diabetes & Endocrinology, P.A. Austin Texas 78731-4309
Research Institute of Dallas Dallas Texas 75231
Diabetes and Thyroid Center of Fort Worth Fort Worth Texas 76132
Endocrine and Psychiatry Center Houston Texas 77095
Southern Endocrinology Associates Mesquite Texas 75149
Texas Diabetes & Endocrinology, P.A. Round Rock Texas 78681
Consano Clinical Research, LLC Shavano Park Texas 78231
Rainier Clinical Research Center Renton Washington 98057

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 21 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04450407, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 26, 2022 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04450407 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →